Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boyle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1159-1160, 2003
© 2003 European Society for Medical Oncology

Editorial

Global summit on mammographic screening

P. Boyle

The first 150 words of the full text of this article appear below.

Forty years of clinical trials, the contribution of hundreds of scientists and health workers and the dedication of hundreds of thousands of women to participate in studies lasting for decades has resulted in adequate evidence to support the efficacy of mammographic screening for breast cancer, which now allows its transfer to the arena of public health policy. Doctors and women can be assured that participation in organised screening programmes, with rigorous quality assurance standards implemented, is of benefit, provided appropriate diagnostic investigation and treatment is available. Special efforts should be made to encourage screening among the more deprived members of society. It is important not to overemphasise the benefit of screening, and to appreciate that this is but one step in the total management of women with the disease. Women should, however, be informed clearly of the level of benefit and of potential risks and costs.

The Milan Global Summit . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
M. Koomen, E. D. Pisano, C. Kuzmiak, D. Pavic, and R. McLelland
Future Directions in Breast Imaging
J. Clin. Oncol., March 10, 2005; 23(8): 1674 - 1677.
[Full Text] [PDF]